Immune Monitoring Solutions Market

Global Immune Monitoring Solutions Market Size, Trends & Analysis - Forecasts to 2027 By Method (Flow Cytometry, Immunohistochemistry, and Others), By Application (Vaccine Development, Transplantation Research, Precision Medicine & Immunotherapy Trials, Allergy Research, Metabolism Studies, and Others), By End-Use (Pharmaceutical and Biopharmaceutical Companies and Government & Academic Research Labs & Institutes), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa), Competitive Landscape Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on December 19 2024 with the latest and most recent market numbers

Immune Monitoring Solutions Market Size

The global immune monitoring solutions market is projected to grow at a CAGR value of 12.9% from 2022 to 2027. The growing investment into the development of novel drugs and vaccines, technological advancements, growing demand for the efficient monitoring of patients, and advancements in data analytics for healthcare are some of the major drivers of the immune monitoring solutions market.

Growing demand for monitoring immune response before and after organ transplants are expected to increase the demand for immune monitoring solutions. The growing number of organ transplants has increased investment in the development and adoption of immune monitoring solutions. Immune monitoring solutions for immunotherapy research protocols have also been growing in demand in recent years. With immune monitoring solutions being increasingly deployed for allergy research and allergy monitoring, the market is expected to thrive owing to the growing instances of people suffering from allergies in the market.

The growing demand for flow cytometry, immunohistochemistry, and single-cell multi-omics is expected to increase the demand for immune monitoring solutions. The growing demand for biologics and personalized drugs have increased the demand for immune monitoring solutions across the globe.

The growing number of viral disease outbreaks have seen an increase in investment for the research and development of novel vaccines. The growing number of clinical trials to study viral outbreaks, allergies, and other immunotherapies are expected to increase the demand for immune monitoring solutions.

The growing investment by manufacturers to manufacture kits, reagents, and other solutions for immune monitoring is expected to have a positive impact on the growth of the market. The increased investment in applying immune monitoring solutions for metabolism studies and autoimmunity research is also expected to drive the immune monitoring solutions.

The COVID-19 pandemic has been responsible for restrictions and lockdowns. These restrictions have restrained the production and manufacturing of reagents and kits thereby restraining the growth of the market. Growing investment in the development of a vaccine for COVID has increased the demand for immune monitoring solutions.

The growth of the immune monitoring solutions market is restrained by the use of cryopreserved samples which can alter the detection capabilities of immune monitoring solutions. Sample collection and the use of specialized markers are all expected to restrain the growth of the market. The high cost of such solutions is expected to restrain the growth of the immune monitoring solutions market.

The immune monitoring solutions market is largely driven by the growing demand for clinical research studies for studying allergies, autoimmune research, increased investment in vaccine development, and technological advancements in the immune monitoring solutions market.

global immune monitoring solutions market

Immune Monitoring Solutions Market: By Method

Based on the method, the immune monitoring solutions market is segmented into flow cytometry, immunohistochemistry, and others. The flow cytometry segment is expected to hold the largest piece of the market during the forecast period. Growing adoption of flow cytometry in research and academia, immune-oncology research, and the proliferation of AI for faster immune monitoring have been the major drivers of the flow cytometry segment. The growing investment in immunotherapy research is expected to increase the demand for flow cytometry-based immune monitoring solutions.

The immunohistochemistry segment is expected to become the fastest-growing segment during the forecast period. The growing demand for immunohistochemistry in clinical trials is expected to contribute to the growth of the immunohistochemistry segment.

Immune Monitoring Solutions Market: By Application

Based on the various avenues of application of immune monitoring solutions, the market is segmented into vaccine development, transplantation research, precision medicine & immunotherapy trials, allergy research, metabolism studies, and others. The vaccine development segment held the lion’s share of the market. The increased investment in vaccine development owing to increased viral outbreaks in recent years has contributed to the growth of the vaccine development segment. The immunotherapy trials segment is expected to become the fastest-growing segment during the forecast period. The immunotherapy segment is largely driven by the increased investment in autoimmune research. The increasing number of people suffering from autoimmune diseases is expected to further increase the demand for immunohistochemistry monitoring solutions.

Immune Monitoring Solutions Market: By End-Use

Based on the various end-use, the market is segmented into pharmaceutical and biopharmaceutical companies and government & academic research labs & institutes. The pharmaceutical and biopharmaceutical companies segment held the lion’s share of the market. Greater availability of investment and capital resources for pharmaceutical and biopharmaceutical companies to conduct clinical research has led to the domination of the pharmaceutical and biopharmaceutical companies segment. This segment is also expected to become the fastest-growing segment during the forecast period.

asia pacific immune monitoring solutions market

Immune Monitoring Solutions Market: By Region

Based on region, the market can be segmented into various regions such as North America, Europe, Central and South America, Middle East and North Africa, and Asia Pacific regions.

The North American region is expected to be the dominant force in the market during the forecast period. A large number of pharmaceutical companies in the region combined with the heavy investment in R&D in the region have contributed to the dominance of the region. The growing development of vaccines in the region, increased investment in autoimmune research, and the strong regulations on pharmaceutical products have led to the domination of the region.

The APAC region is expected to become the fastest-growing segment during the forecast period. The growing pharmaceuticals manufacturing in the region and growing investment in academic research labs and institutes are some of the major drivers of the APAC region.

Immune Monitoring Solutions Market Share and Competitor Analysis

BD, Creative Biolabs, Precision Medicine Group, LLC., Beckman Coulter, Inc., Q2 Solutions and (Rules-Based Medicine), Medigene AG, and ImmuMap Services ApS, among others, are the key players in the immune monitoring solutions market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Methodology

1.1 Market Scope & Definitions

1.2 Estimates & Forecast Calculation

1.3 Historical Data Overview and Validation

1.4 Data Sources

1.4.1 Secondary

1.4.2 Primary

Chapter 2 Report Outlook

2.1 Digital Immune Monitoring Solutions Industry Overview, 2021-2027

2.1.1 Industry Overview

2.1.2 Method Overview

2.1.3 Application Overview

2.1.4 End-Use Overview

2.1.6 Regional Overview

Chapter 3 Digital Immune Monitoring Solutions Market Trends

3.1 Market Segmentation

3.2 Industry Background, 2021-2027

3.3 Market Key Trends

3.3.1 Positive Trends

3.3.1.1 Rising investment in clinical research studies

3.3.2 Industry Challenges

3.3.2.1 High cost of immune monitoring solutions

3.4 Prospective Growth Scenario

3.4.1 Method Growth Scenario

3.4.2 Application Growth Scenario

3.4.3 End-Use Growth Scenario

3.5 COVID-19 Influence over Industry Growth

3.6 Porter’s Analysis

3.7 PESTEL Analysis

3.8 Value Chain & Supply Chain Analysis

3.9 Regulatory Framework

3.9.1 North America

3.9.2 Europe

3.9.3 APAC

3.9.4 LATAM

3.9.5 MEA

3.10 End-Use Overview

3.11 Market Share Analysis, 2021

3.11.1 Company Positioning Overview, 2021

Chapter 4 Digital Immune Monitoring Solutions Market, By Method

4.1 Method Outlook

4.2 Flow Cytometry

4.2.1 Market Size, By Region, 2021-2027 (USD Million)

4.3 Immunohistochemistry

4.3.1 Market Size, By Region, 2021-2027 (USD Million)

4.4 Others

4.4.1 Market Size, By Region, 2021-2027 (USD Million)

Chapter 5 Digital Immune Monitoring Solutions Market, By Application

5.1 Application Outlook

5.2 Vaccine Development

5.2.1 Market Size, By Region, 2021-2027 (USD Million)

5.3 Transplantation Research

5.3.1 Market Size, By Region, 2021-2027 (USD Million)

5.4 Precision Medicine & Immunotherapy Trials

5.4.1 Market Size, By Region, 2021-2027 (USD Million)

5.5 Allergy Research

5.5.1 Market Size, By Region, 2021-2027 (USD Million)

5.6 Metabolism Studies

5.6.1 Market Size, By Region, 2021-2027 (USD Million)

5.7 Others

5.7.1 Market Size, By Region, 2021-2027 (USD Million)

Chapter 6 Digital Immune Monitoring Solutions Market, By End-Use

6.1 Pharmaceutical and Biopharmaceutical Companies

6.1.1 Market Size, By Region, 2021-2027 (USD Million)

6.2 Government & Academic Research Labs & Institutes

6.2.1 Market Size, By Region, 2021-2027 (USD Million)

Chapter 7 Digital Immune Monitoring Solutions Market, By Region

7.1 Regional outlook

7.2 North America

7.2.1 Market Size, By Country 2021-2027 (USD Million)

7.2.2 Market Size, By Method, 2021-2027 (USD Million)

7.2.3 Market Size, By Application, 2021-2027 (USD Million)

7.2.4 Market Size, By End-Use, 2021-2027 (USD Million)

7.2.5 U.S.

7.2.5.1 Market Size, By Method, 2021-2027 (USD Million)

7.2.5.2 Market Size, By Application, 2021-2027 (USD Million)

7.2.5.3 Market Size, By End-Use, 2021-2027 (USD Million)

7.2.6 Canada

7.2.6.1 Market Size, By Method, 2021-2027 (USD Million)

7.2.6.2 Market Size, By Application, 2021-2027 (USD Million)

7.2.6.3 Market Size, By End-Use, 2021-2027 (USD Million)

7.3 Europe

7.3.1 Market Size, By Country 2021-2027 (USD Million)

7.3.2 Market Size, By Method, 2021-2027 (USD Million)

7.3.3 Market Size, By Application, 2021-2027 (USD Million)

7.3.4 Market Size, By End-Use, 2021-2027 (USD Million)

7.3.6 Germany

7.3.6.1 Market Size, By Method, 2021-2027 (USD Million)

7.3.6.2 Market Size, By Application, 2021-2027 (USD Million)

7.3.6.3 Market Size, By End-Use, 2021-2027 (USD Million)

7.3.7 UK

7.3.7.1 Market Size, By Method, 2021-2027 (USD Million)

7.3.7.2 Market Size, By Application, 2021-2027 (USD Million)

7.3.7.3 Market Size, By End-Use, 2021-2027 (USD Million)

7.3.8 France

7.3.7.1 Market Size, By Method, 2021-2027 (USD Million)

7.3.7.2 Market Size, By Application, 2021-2027 (USD Million)

7.3.7.3 Market Size, By End-Use, 2021-2027 (USD Million)

7.3.9 Italy

7.3.9.1 Market Size, By Method, 2021-2027 (USD Million)

7.3.9.2 Market Size, By Application, 2021-2027 (USD Million)

7.3.9.3 Market Size, By End-Use, 2021-2027 (USD Million)

7.3.10 Spain

7.3.10.1 Market Size, By Method, 2021-2027 (USD Million)

7.3.10.2 Market Size, By Application, 2021-2027 (USD Million)

7.3.10.3 Market Size, By End-Use, 2021-2027 (USD Million)

7.3.11 Russia

7.3.11.1 Market Size, By Method, 2021-2027 (USD Million)

7.3.11.2 Market Size, By Application, 2021-2027 (USD Million)

7.3.11.3 Market Size, By End-Use, 2021-2027 (USD Million)

7.4 Asia Pacific

7.4.1 Market Size, By Country 2021-2027 (USD Million)

7.4.2 Market Size, By Method, 2021-2027 (USD Million)

7.4.3 Market Size, By Application, 2021-2027 (USD Million)

7.4.4 Market Size, By End-Use, 2021-2027 (USD Million)

7.4.6 China

7.4.6.1 Market Size, By Method, 2021-2027 (USD Million)

7.4.6.2 Market Size, By Application, 2021-2027 (USD Million)

7.4.6.3 Market Size, By End-Use, 2021-2027 (USD Million)

7.4.7 India

7.4.7.1 Market Size, By Method, 2021-2027 (USD Million)

7.4.7.2 Market Size, By Application, 2021-2027 (USD Million)

7.4.7.3 Market Size, By End-Use, 2021-2027 (USD Million)

7.4.8 Japan

7.4.7.1 Market Size, By Method, 2021-2027 (USD Million)

7.4.7.2 Market Size, By Application, 2021-2027 (USD Million)

7.4.7.3 Market Size, By End-Use, 2021-2027 (USD Million)

7.4.9 Australia

7.4.9.1 Market Size, By Method, 2021-2027 (USD Million)

7.4.9.2 Market size, By Application, 2021-2027 (USD Million)

7.4.9.3 Market Size, By End-Use, 2021-2027 (USD Million)

7.4.10 South Korea

7.4.10.1 Market Size, By Method, 2021-2027 (USD Million)

7.4.10.2 Market Size, By Application, 2021-2027 (USD Million)

7.4.10.3 Market Size, By End-Use, 2021-2027 (USD Million)

7.5 Latin America

7.5.1 Market Size, By Country 2021-2027 (USD Million)

7.5.2 Market Size, By Method, 2021-2027 (USD Million)

7.5.3 Market Size, By Application, 2021-2027 (USD Million)

7.5.4 Market Size, By End-Use, 2021-2027 (USD Million)

7.5.6 Brazil

7.5.6.1 Market Size, By Method, 2021-2027 (USD Million)

7.5.6.2 Market Size, By Application, 2021-2027 (USD Million)

7.5.6.3 Market Size, By End-Use, 2021-2027 (USD Million)

7.5.7 Mexico

7.5.7.1 Market Size, By Method, 2021-2027 (USD Million)

7.5.7.2 Market Size, By Application, 2021-2027 (USD Million)

7.5.7.3 Market Size, By End-Use, 2021-2027 (USD Million)

7.5.8 Argentina

7.5.7.1 Market Size, By Method, 2021-2027 (USD Million)

7.5.7.2 Market Size, By Application, 2021-2027 (USD Million)

7.5.7.3 Market Size, By End-Use, 2021-2027 (USD Million)

7.6 MEA

7.6.1 Market Size, By Country 2021-2027 (USD Million)

7.6.2 Market Size, By Method, 2021-2027 (USD Million)

7.6.3 Market Size, By Application, 2021-2027 (USD Million)

7.6.4 Market Size, By End-Use, 2021-2027 (USD Million)

7.6.6 Saudi Arabia

7.6.6.1 Market Size, By Method, 2021-2027 (USD Million)

7.6.6.2 Market Size, By Application, 2021-2027 (USD Million)

7.6.6.3 Market Size, By End-Use, 2021-2027 (USD Million)

7.6.7 UAE

7.6.7.1 Market Size, By Method, 2021-2027 (USD Million)

7.6.7.2 Market Size, By Application, 2021-2027 (USD Million)

7.6.7.3 Market Size, By End-Use, 2021-2027 (USD Million)

7.6.8 South Africa

7.6.7.1 Market Size, By Method, 2021-2027 (USD Million)

7.6.7.2 Market Size, By Application, 2021-2027 (USD Million)

7.6.7.3 Market Size, By End-Use, 2021-2027 (USD Million)

Chapter 8 Company Landscape

8.1 Competitive Analysis, 2021

8.2 BD

8.2.1 Company Overview

8.2.2 Financial Analysis

8.2.3 Strategic Positioning

8.2.4 Info Graphic Analysis

8.3 Creative Biolabs

8.3.1 Company Overview

8.3.2 Financial Analysis

8.3.3 Strategic Positioning

8.3.4 Info Graphic Analysis

8.4 Precision Medicine Group, LLC.

8.4.1 Company Overview

8.4.2 Financial Analysis

8.4.3 Strategic Positioning

8.4.4 Info Graphic Analysis

8.5 Beckman Coulter, Inc.

8.5.1 Company Overview

8.5.2 Financial Analysis

8.5.3 Strategic Positioning

8.5.4 Info Graphic Analysis

8.6 Q2 Solutions (Rules-Based Medicine)

8.6.1 Company Overview

8.6.2 Financial Analysis

8.6.3 Strategic Positioning

8.6.4 Info Graphic Analysis

8.7 Medigene AG

8.7.1 Company Overview

8.7.2 Financial Analysis

8.7.3 Strategic Positioning

8.7.4 Info Graphic Analysis

8.8 ImmuMap Services ApS

8.8.1 Company Overview

8.8.2 Financial Analysis

8.8.3 Strategic Positioning

8.8.4 Info Graphic Analysis

8.9 Other Companies

8.9.1 Company Overview

8.9.2 Financial Analysis

8.9.3 Strategic Positioning

8.9.4 Info Graphic Analysis

The Global Immune Monitoring Solutions Market has been studied from the year 2019 till 2027. However, the CAGR provided in the report is from the year 2022 to 2027. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Immune Monitoring Solutions Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the global immune monitoring solutions market?

The global immune monitoring solutions market size is projected to grow at a CAGR value of 12.9% from 2022 and 2027.

Who are the major vendors in the immune monitoring solutions market?

Key and innovative vendors in the immune monitoring solutions market include BD, Creative Biolabs, Precision Medicine Group, LLC., Beckman Coulter, Inc., Q2 Solutions and (Rules-Based Medicine), Medigene AG, and ImmuMap Services ApS, among others.

Which region has the highest market share in the immune monitoring solutions market?

The North American region is estimated to hold the largest share of the immune monitoring solutions market.

What is the Covid-19 impact on future immune monitoring solutions manufacturers?

What are the major drivers in the immune monitoring solutions market?